Literature DB >> 3355262

Phenytoin in rheumatoid arthritis.

K A Grindulis, F E Nichol, R Oldham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3355262      PMCID: PMC1003499          DOI: 10.1136/ard.47.3.261-a

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  Pilot study of phenytoin in rheumatoid arthritis.

Authors:  D G Macfarlane; B Clark; G S Panayi
Journal:  Ann Rheum Dis       Date:  1986-11       Impact factor: 19.103

2.  Progression of radiological changes in rheumatoid arthritis.

Authors:  D L Scott; K A Grindulis; G R Struthers; B L Coulton; A J Popert; P A Bacon
Journal:  Ann Rheum Dis       Date:  1984-02       Impact factor: 19.103

3.  Phenytoin therapy of recessive dystrophic epidermolysis bullosa. Clinical trial and proposed mechanism of action on collagenase.

Authors:  E A Bauer; T W Cooper; D R Tucker; N B Esterly
Journal:  N Engl J Med       Date:  1980-10-02       Impact factor: 91.245

4.  Comparison of phenytoin and gold as second line drugs in rheumatoid arthritis.

Authors:  I M Richards; S M Fraser; J A Hunter; H A Capell
Journal:  Ann Rheum Dis       Date:  1987-09       Impact factor: 19.103

5.  Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression.

Authors:  P T Dawes; P D Fowler; S Clarke; J Fisher; A Lawton; M F Shadforth
Journal:  Br J Rheumatol       Date:  1986-02

6.  Phenytoin in rheumatoid arthritis.

Authors:  K A Grindulis; F E Nichol; R Oldham
Journal:  J Rheumatol       Date:  1986-12       Impact factor: 4.666

7.  Diphenylhydantoin (dilantin) gingival hyperplasia: drug-induced abnormality of connective tissue.

Authors:  T M Hassell; R C Page; A S Narayanan; C G Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.